News

A new tumor staging system for cutaneous squamous cell carcinoma (CSCC) has recently been put forward that, according to one recent study, improves prognostic discrimination by more precisely defining the small subset of tumors with a high risk of metastatic and death.

Atypical fibroxanthoma (AFX) and undifferentiated pleomorphic sarcoma (UPS) share a similar histological picture. But unlike AFX, UPS can have an aggressive clinical course, underscoring the importance of initial accurate diagnosis of these tumors, and the implementation of appropriate therapy.

Antiperspirants and not deodorants are the culprit in skin irritation. The antiperspirant decreases sweating while the deodorant simply provides a pleasant scent to the armpit.

We are often asked to help doctors to protect assets against future lawsuits. From this experience, we often learn what misconceptions physicians have regarding how to protect their assets from potential lawsuits.

Do you have a Facebook marketing strategy for your dermatology practice? Without a strategy and definitive goals to market your practice, you won’t be able to reach the people that need skincare services.

The Orlando Dermatology Aesthetic and Clinical Conference, held Jan. 17-20 in Orlando, Fla., has several changes in store for 2014.

A study shows data to suggest there is evidence of subtype progression in rosacea, and that flushing is not a universal characteristic of patients with subtype 1 rosacea.

As 2013 came to a close, Dermatology Times asked some of its editorial advisory board members what they considered to be some of the most clinically relevant advances in the past year.

New research indicates that outer skin cells are able to unite to form a bridge during wound healing. The finding may lead to advances in tissue engineering, artificial skin design and improved wound treatment.

Researchers may have found a new technique for identifying suspicious-looking moles: crowdsourcing.

Sandoz has begun a phase 3 trial of a biosimilar version of adalimumab (Humira, AbbVie) for moderate-to-severe plaque psoriasis.

What does the future look like for cosmetic medicine and aesthetic treatments? Jwala Karnik, M.D., chief medical officer, Suneva Medical, weighs in on three trends that are expected to impact cosmetic dermatology.

Results of a Johns Hopkins study suggest that cancer triggers the autoimmune disease scleroderma.

The Food and Drug Administration has proposed a rule that would require manufacturers of antibacterial hand soaps to demonstrate that their products are safe and effective.

A team of dermatologists is beta testing a website designed as a tool to provide early detection of skin cancer.

Patients with atopic dermatitis are more likely than those without the condition to have allergic reactions to formaldehyde releasers found in skin creams, according to a recent study.

A new study suggests that topical 5-fluorouracil (5-FU) may increase the risk of morpheaform basal cell carcinoma (mBCC) in patients with previous skin cancers.

The American Academy of Dermatology has issued new guidelines for the diagnosis and assessment of atopic dermatitis.

Researchers have identified a molecular pathway that, when activated, can stimulate hair growth in dormant hair follicles.

Blood vessels in face transplant recipients reorganize themselves, according to study findings that could expand the medical community’s understanding of biologic changes that occur following such transplants.

Excessive scarring, particularly hypertrophic scars, can be treated effectively with currently available laser treatments, results of a recent study suggest.

Smartphone applications (apps) have become very popular in mainstream medicine and dermatology. Though the use of apps can and should not replace clinical judgment or physician interaction, smartphone apps can be practical and helpful in facilitating dermatologic care on both sides of the physician-patient spectrum.

Patient compliance to suggested therapy, whether topic or oral, remains the major obstacle in achieving good treatment outcomes in dermatology. Establishing trust with the patient, choosing a treatment plan that the patient likes, and scheduling the follow-up visit soon after first presentation are all key steps the physician can take in helping to improve patient compliance and further, treatment outcomes.

A newly launched diagnostic test by Myriad Genetics can differentiate malignant melanoma from benign skin lesions.

We now have three neurotoxins in our marketplace. Do you feel that these neurotoxins differ, and if so, how? An expert panel addresses the topic at the 2013 Vegas Cosmetic Surgery and Aesthetic Dermatology meeting.

The Food and Drug Administration has approved Varithena (polidocanol injectable foam, BTG International) for the treatment of varicose veins.

A dilute bleach solution may be an effective way to treat certain inflammatory skin conditions, according to a new study.

According to an opinion piece published in JAMA Dermatology, when considering the appropriate ages for aesthetic procedures, the question isn’t so much, “What age is too young” as it is, “What age is too old?”

A recent study has determined that some academic journals use social media such as Facebook and Twitter to greatly increase their exposure to a wider audience.

A topical gel, Valchlor (mechlorethamine, Actelion), is now available in the United States for patients with stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma.